A US listed immunotherapy company company just started a phase 111 trial for 800 patients with Head and Neck Cancer. The trial will take place in 9 countries including the USA.
They have listed the cost of the trial at 26 million USD. One would think Prima's cost with 750 patients would be similar.
sellers, page-51
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.8¢ |
Change
0.003(0.79%) |
Mkt cap ! $461.8M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 32.0¢ | 31.0¢ | $173.4K | 551.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 27127 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 159913 | 16 |
View Market Depth
| Last trade - 10.54am 10/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |